Literature DB >> 16773963

Neuroleptic malignant syndrome: need for early diagnosis and therapy.

Humaira M Khan1, Nadir A Syed, Mughis Sheerani, Bhojo Khcalani, Ayeesha Kamal, Mohammad Wasay.   

Abstract

BACKGROUND: Neuroleptic Malignant Syndrome (NMS) is a medical entity that has received little attention in the clinical settings in Pakistan. The aim of our study was to review the predisposing factors, outcomes and characteristics of in-patients diagnosed with NMS.
METHODS: We performed a retrospective chart review of all cases (age >15 years) at a tertiary care center in Karachi between January 01, 1990 and November 30, 2001, diagnosed using ICD 10 coding. Data was collected using a standardized data entry form and statistical analysis was performed using Epi Info 6, Version 6.02.
RESULTS: There were a total of 20 patients diagnosed with NMS (11 male and 9 female) in our study with a mean age of 46.6 +/- 15.9 years. Haloperidol was the most frequently responsible neuroleptic. Of the 18 patients on a neuroleptic, most developed NMS after 8 weeks of therapy. There were 5 mortalities all of which were associated with septic shock. Fourteen patients recovered completely from the episode and did not have any neurologic sequelae.
CONCLUSIONS: NMS is an important preventable clinical entity. Early diagnosis and judicious use of antipsychotics is warranted to prevent mortality and heightened morbidity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773963

Source DB:  PubMed          Journal:  J Ayub Med Coll Abbottabad        ISSN: 1025-9589


  1 in total

1.  [A neuroleptic malignant syndrome complicated by subarachnoid hemorrhage and revealing cerebral vasculitis].

Authors:  Toufik Jouali; Brahim Boukatta; Brahim Bechri; Nawfel Houari; Abderahim Bouazzaoui; Hicham Sbai; Nabil Kanjaa
Journal:  Pan Afr Med J       Date:  2014-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.